thalidomide has been researched along with Vulvar Diseases in 7 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Vulvar Diseases: Pathological processes of the VULVA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report one case of Langerhans cell histiocytosis in a 33-year-old woman with resistant vulvar involvement whose cutaneous lesions improved with thalidomide." | 1.30 | [Langerhans histiocytosis in adults: cutaneous and mucous lesion regression after treatment with thalidomide]. ( Blot, E; Boullié, MC; Cailleux, N; Courtois, H; Courville, P; Lair, G; Lauret, P; Lévesque, H; Marie, I, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, C | 1 |
| Ruiz Beguerie, J | 1 |
| Fernández, J | 1 |
| Stringa, MF | 1 |
| Anaya, J | 1 |
| Kolivras, A | 1 |
| De Maubeuge, J | 1 |
| André, J | 1 |
| Song, M | 1 |
| Staumont-Sallé, D | 1 |
| Magro, L | 1 |
| Piette, F | 1 |
| Thomas, P | 1 |
| Jouet, JP | 1 |
| Catteau, B | 1 |
| Santillan, A | 1 |
| Montero, AJ | 1 |
| Kavanagh, JJ | 1 |
| Liu, J | 1 |
| Ramirez, PT | 1 |
| Verberkmoes, A | 1 |
| Boer, K | 1 |
| Wertheim, PM | 1 |
| Bronkhorst, CM | 1 |
| Lange, JM | 1 |
| Lair, G | 1 |
| Marie, I | 1 |
| Cailleux, N | 1 |
| Blot, E | 1 |
| Boullié, MC | 1 |
| Courville, P | 1 |
| Lauret, P | 1 |
| Lévesque, H | 1 |
| Courtois, H | 1 |
1 review available for thalidomide and Vulvar Diseases
| Article | Year |
|---|---|
Vulvar Langerhans cell histiocytosis: a case report and review of the literature.
Topics: Adult; Combined Modality Therapy; Female; Histiocytosis, Langerhans-Cell; Humans; Thalidomide; Vulva | 2003 |
6 other studies available for thalidomide and Vulvar Diseases
| Article | Year |
|---|---|
Red plaques and tumors on the vulva.
Topics: Asymptomatic Diseases; Female; Glucocorticoids; Histiocytosis, Langerhans-Cell; Humans; Immunosuppre | 2019 |
Vulvar Langerhans cell histiocytosis and thalidomide: an effective treatment option.
Topics: Female; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Middle Aged; Thalidomide; | 2017 |
Thalidomide in refractory vulvar ulcerations associated with Crohn's disease.
Topics: Adult; Crohn Disease; Female; Humans; Immunosuppressive Agents; Thalidomide; Treatment Outcome; Ulce | 2003 |
Chronic graft-versus-host disease revealed by lichenoid vulvar lesions successfully treated with thalidomide.
Topics: Administration, Oral; Adult; Bone Marrow Transplantation; Diagnosis, Differential; Female; Graft vs | 2003 |
Thalidomide for genital ulcer in HIV-positive woman.
Topics: Adult; Female; Herpes Genitalis; HIV Seropositivity; HIV-1; Humans; Thalidomide; Ulcer; Vulvar Disea | 1996 |
[Langerhans histiocytosis in adults: cutaneous and mucous lesion regression after treatment with thalidomide].
Topics: Adult; Dermatologic Agents; Female; Histiocytosis, Langerhans-Cell; Humans; Patient Compliance; Recu | 1998 |